We investigated the incidence of the KIF5B-RET fusion gene in Korean NSCLC patients, and attempted to identify the cases in which this fusion gene occurred concurrently with EGFR or KRAS mutations. This evidence concerns the gene EGFR and non-small cell lung carcinoma.